Top 15 hepatitis C treatment clinics in the United States: A Journalistic Evaluation of Specialized Liver Care Centers

Epidemiology of Hepatitis C and the Clinical Landscape

Chronic viral hepatitis remains a significant public health challenge in the United States, affecting millions. The Centers for Disease Control and Prevention (CDC) estimates that between 2.4 and 4 million individuals lived with chronic hepatitis C virus (HCV) between 2017 and 2020 1. Left untreated, this bloodborne pathogen can lead to severe clinical complications, including liver scarring, liver failure, and liver cancer 1 2.

In 2023, the CDC documented approximately 69,000 new acute cases and over 101,000 newly reported chronic cases 3. The highest rates of acute infection occur in adults aged 20 to 39, with roughly 43% of cases linked to injection drug use 1. Public health strategies emphasize the critical role of specialized clinical programs to deliver prompt, structured, and accessible care across different regions 3 4.

Leading Academic Centers for Specialized Hepatology

Top-tier academic medical systems are primary destinations for complex liver evaluations. The Mayo Clinic, with campuses in Minnesota, Florida, and Arizona, consistently ranks as a premier center for gastroenterology and advanced liver surgery. It utilizes multidisciplinary teams of hepatologists. Similarly, the Cleveland Clinic in Ohio offers highly integrated diagnostic and treatment programs, managing advanced liver damage and providing evaluation for liver transplant candidates.

In the Mid-Atlantic, the Johns Hopkins Viral Hepatitis Center in Baltimore provides specialized care for complex cases. These academic centers utilize advanced diagnostic tools, such as transient elastography, to measure liver stiffness and assess fibrosis without invasive surgical biopsies. They also provide access to ongoing clinical trials, offering patients opportunities to participate in research on novel therapeutic interventions and long-term viral clearance.

Regional Referral Centers on the East and West Coasts

Coastal metropolitan regions support crucial medical centers specializing in viral hepatitis. The University of California, San Francisco (UCSF) Medical Center operates a leading hepatitis C clinic that specializes in treating patients with advanced cirrhosis and HIV co-infection. On the East Coast, Mount Sinai Hospital in New York City is recognized for managing liver disease, especially in complex patients with chronic comorbidities and multiple medical needs.

Additionally, the University of Washington Medical Center in Seattle operates the Hepatitis C Online platform, a major educational resource for clinical providers across the country 5. In California, Cedars-Sinai Medical Center in Los Angeles provides advanced diagnostics and clinical trial access. These centers represent critical pieces of the nation's tertiary healthcare infrastructure, addressing treatment-experienced patients who have failed prior regimens.

Integrated Care and Public Healthcare Networks

Integrating hepatology into broader primary care and public systems is essential for expanding clinical access. Massachusetts General Hospital in Boston integrates specialty hepatology with infectious disease clinics to manage cases involving severe comorbidities. Similarly, the University of Michigan Health System utilizes clinical protocols to deliver patient-centered, genotype-specific care. These models ensure that patients receive thorough pre-treatment staging and close laboratory monitoring.

On a national scale, the United States Department of Veterans Affairs (VA) operates one of the largest integrated hepatitis C treatment programs. Through regional clinics, the VA has systematically treated and cured thousands of veterans utilizing standardized care pathways. In Pennsylvania, the University of Pennsylvania Health System provides comprehensive hepatology services, offering a robust safety net for patients requiring complex, multi-system management for advanced liver pathology.

Regional Telemedicine and Community Clinic Programs

Telehealth programs have significantly expanded the reach of clinical specialists into remote areas. For instance, Oregon Health & Science University (OHSU) coordinates the OR-HOPE Telemedicine clinical trials to support patients in rural settings 6. Likewise, low-cost community health centers, such as those in Georgia, provide vital local treatment for non-cirrhotic, treatment-naive individuals 7. These programs reduce barriers to care by bringing medical evaluations directly to historically underserved populations 6 7.

Digital health platforms, including the Klinic network, connect patients with independent, board-certified providers across multiple states, including New Jersey, North Carolina, Indiana, Utah, Missouri, and Tennessee 8. These virtual networks allow patients to schedule appointments, coordinate diagnostic laboratory work, and manage prescriptions from their homes 8. This approach avoids long waitlists often found at larger, centralized metropolitan university medical centers 8.

Pharmaceutical Protocols and Direct-Acting Antiviral Agents

Modern hepatitis C treatment relies almost exclusively on oral direct-acting antiviral (DAA) medications. These highly effective therapies can clear the virus in as little as 8 to 12 weeks, achieving cure rates exceeding 95% 2 3. Commonly prescribed treatments include Epclusa, which targets every major genotype 8, and Mavyret, which can clear the virus in an 8-week course 8. These tablets stop the virus from replicating, allowing the liver to begin healing 8.

For cases where past treatments have failed, clinicians utilize salvage regimens such as Vosevi, which blocks the virus at three points 8. Other therapies, including Harvoni, Sovaldi, and Zepatier, provide clinical options tailored to specific genotypes and patient health profiles 8. While highly successful, accessing these medications requires thorough clinical evaluation, proper insurance authorization, or safety-net pharmacy support 3 8.

Diagnostics, Monitoring, and National Elimination Efforts

Effective disease management begins with rigorous initial screening and confirmatory testing. Standard protocols require an FDA-approved hepatitis C antibody test followed by reflex RNA testing to confirm active viral infection 9. A single-draw reflex approach simplifies the clinical pathway and reduces patient drop-off between screening and treatment 9. Standard liver function tests, such as measuring elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST), help monitor liver health 7.

Despite highly effective treatments, researchers from the CDC and Quest Diagnostics have documented significant gaps in care 3. Their studies show that a large percentage of diagnosed patients fail to complete follow-up testing or start antiviral therapy 3. To combat this, bipartisan legislative initiatives like the Cure Hepatitis C Act have been introduced to establish federally coordinated testing and treatment programs to eliminate the virus nationwide 10.

Sources

1. Centers for Disease Control and Prevention - Hepatitis C Basics
2. World Health Organization - Hepatitis C Fact Sheet
3. HepMag - Gaps in Treatment and Testing
4. Hepatology Journal - Global Hepatitis C Elimination Updates
5. University of Washington - Hepatitis C Online
6. Oregon Health & Science University - Clinical Trials
7. Infectious Disease Advisor - Low-Cost Community Clinics
8. Klinic Network - Direct-Acting Antiviral Services
9. Dr. Oracle - Laboratory Testing Guidelines
10. United States Congress - Cure Hepatitis C Act of 2026